Shares of Ondine Biomedical Inc. (LON:OBI - Get Free Report) were up 0.3% during trading on Friday . The stock traded as high as C$9.28 and last traded at C$9.28. Approximately 5,323 shares were traded during trading, a decline of 98% from the average daily volume of 279,142 shares. The stock had previously closed at C$9.25.
Ondine Biomedical Stock Down 3.9 %
The company has a debt-to-equity ratio of 25.95, a quick ratio of 8.26 and a current ratio of 1.36. The firm's 50 day moving average price is C$9.87 and its two-hundred day moving average price is C$9.45. The company has a market cap of C$62.19 million, a P/E ratio of -2.61 and a beta of 0.10.
Insider Activity
In related news, insider Carolyn Cross acquired 149,225 shares of the firm's stock in a transaction on Monday, February 3rd. The stock was purchased at an average cost of C$13.00 per share, with a total value of C$1,939,925.00. Company insiders own 36.69% of the company's stock.
Ondine Biomedical Company Profile
(
Get Free Report)
Ondine Biomedical is a life sciences company leading the charge in breakthrough photodisinfection-based therapies to prevent and treat serious infections, including those caused by existing, emerging, and antimicrobial-resistant pathogens.
Our vision is a world free from infections. We have created a patented, platform technology (photodisinfection) to provide simple solutions to complex infections across different therapeutic areas in healthcare and industry settings.
Read More
Before you consider Ondine Biomedical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ondine Biomedical wasn't on the list.
While Ondine Biomedical currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
